At a glance
ClinicalIndex Comparison RecordN/ACompleted· 56 enrolled
Drug / intervention
(Cosopt®, prostaglandin)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data
In Brief
An observational study evaluating (Cosopt®, prostaglandin) for Glaucoma. Completed, enrolled 56 participants across 1 site.
Detailed Summary
To analyze Cosopt® in terms of its effects on ocular perfusion pressure and comprehensive ocular blood flow and in relation to visual field progression and optic nerve structural changes in an ongoing 3 year prospective study involving 120 patients with open angle glaucoma.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
First PostedJun 2010
Primary CompletionJan 2012
Study CompletionOct 2012
TodayJul 2026
First PostedJun 17, 2010
Enrollment StartJun 1, 2010
Primary CompletionJan 1, 2012
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 16.0 years ago
Interventions
(Cosopt®, prostaglandin)drug
We did NOT provide any intervention, we observed groups of patients already on these drugs as observers only.